Erratum: blaNDM-5-Bearing IncFIIType Plasmids of Klebsiella pneumoniae Sequence Type 147 Transmitted by Cross-Border Transfer of a Patient (Antimicrobial Agents and Chemotherapy (2016) 60 (1932-1934) DOI: 10.1128/AAC.02722-15);BlaNDM-5-Bearing IncFII-type plasmids of Klebsiella pneumoniae sequence type 147 transmitted by cross-border transfer of a patient

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 3, 2016, Pages 1932-1934

  Shin, Juyoun ^a   Baek, Jin Yang ^b   Cho, Sun Young ^a   Huh, Hee Jae ^a   Lee, Nam Yong ^a   Song, Jae Hoon ^a,b   Chung, Doo Ryeon ^a,b   Ko, Kwan Soo ^a,b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Asia Pacific Foundation for Infectious Diseases   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL GENE; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; ESCHERICHIA COLI; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; KLEBSIELLA PNEUMONIAE; KOREAN (PEOPLE); NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; SOUTH KOREA; UNITED ARAB EMIRATES; CROSS INFECTION; DNA SEQUENCE; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; PATIENT TRANSPORT;

ANTIINFECTIVE AGENT; BETA LACTAMASE;

ANTI-BACTERIAL AGENTS; BASE SEQUENCE; BETA-LACTAMASES; CROSS INFECTION; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; PATIENT TRANSFER; PLASMIDS; REPUBLIC OF KOREA; SEQUENCE ANALYSIS, DNA; UNITED ARAB EMIRATES;

EID: 84960157517     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02221-21     Document Type: Erratum

References (19)

1. Shrestha B, Tada T, Miyoshi-Akiyama T, Shimada K, Ohara H, Kirikae T, Pokhrel BM. 2015. Identification of a novel variant, NDM-13, from a multidrug-resistant Escherichia coli from Nepal. Antimicrob Agents Chemother 59:5847-5850. http://dx.doi.org/10.1128/AAC.00332-15.
2. Hornsey M, Phee L, Wareham DW. 2011. A novel variant, NDM-5, of the New Delhi metallo-β-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob Agents Chemother 55:5952-5954. http://dx.doi.org/10.1128/AAC.05108-11.
3. NDM-5 carried by an IncX3 plasmid in Escherichia coli sequence type 167. Antimicrob Agents Chemother 58:7548-7552. http://dx.doi.org/10.1128/AAC.03911-14.
4. Nakano R, Nakano A, Hikosaka K, Kawakami S, Matsunaga N, Asahara M, Ishigaki S, Furukawa T, Suzuki M, Shibayama K, Ono Y. 2014. First report of metallo-β-lactamase NDM-5-producing Escherichia coli in Japan. Antimicrob Agents Chemother 58:7611-7612. http://dx.doi.org/10.1128/AAC.04265-14.
5. NDM-5 carried on an IncFII plasmid in an Escherichia coli isolate from a nontraveler patient in Spain. Antimicrob Agents Chemother 59:659-662. http://dx.doi.org/10.1128/AAC.04040-14.
6. Rahman M, Shukla SK, Prasad KN, Ovejero CM, Pati BK, Tripathi A, Singh A, Srivastava AK, Gonzalez-Zorn B. 2014. Prevalence and molecular characterization of New Delhi metallo-β-lactamases NDM-1, NDM-5, NDM-6, and NDM-7 in multidrug-resistant Enterobacteriaceae from India. Int J Antimicrob Agents 44:30-37. http://dx.doi.org/10.1016/j.ijantimicag.2014.03.003.
7. Sassi A, Loucif L, Gupta SK, Dekhil M, Chettibi H, Rolain JM. 2014. NDM-5 carbapenemase-encoding gene in multidrug-resistant clinical isolates of Escherichia coli from Algeria. Antimicrob Agents Chemother 58:5606-5608. http://dx.doi.org/10.1128/AAC.02818-13.
8. Cho SY, Huh HJ, Baek JY, Chung NY, Ryu JG, Ki CS, Chung DR, Lee NY, Song JH. 2015. Klebsiella pneumoniae coproducing NDM-5 and OXA-181 carbapenemases, South Korea. Emerg Infect Dis 21:1088-1089. http://dx.doi.org/10.3201/eid2106.150048.
9. Song W, Lee H, Lee K, Jeong SH, Bae IK, Kim JS, Kwak HS. 2009. CTX-M-14 and CTX-M-15 enzymes are the dominant type of extendedspectrum β-lactamase in clinical isolates of Escherichia coli from Korea. J Med Microbiol 58:261-266. http://dx.doi.org/10.1099/jmm.0.004507-0.
10. Bonnin RA, Poirel L, Carattoli A, Nordmann P. 2012. Characterization of an IncFII plasmid of an IncFII plasmid encoding NDM-1 from Escherichia coli ST131. PLoS One 7:e34752. http://dx.doi.org/10.1371/journal.pone.0034752.
11. Fiett J, Baraniak A, Izdebski R, Sitkiewicz I, Zábicka D, Meler A, Filczak K, Hryniewicz W, Gniadkowski M. 2014. The first NDM metallo-β-lactamase-producing Enterobacteriaceae isolate in Poland: evolution of IncFII-type plasmids carrying the blaNDM-1 gene. Antimicrob Agents Chemother 58:1203-1207. http://dx.doi.org/10.1128/AAC.01197-13.
12. Boyd DA, Tyler S, Christianson S, McGeer A, Muller MP, Willey BM, Bryce E, Gardam M, Nordmann P, Mulvey MR. 2004. Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extendedspectrum β-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob Agents Chemother 48:3758-3764. http://dx.doi.org/10.1128/AAC.48.10.3758-3764.2004.
13. Ho PL, Chan J, Law PY, Law PW, Chow KH. 2013. Plasmid-mediated fosfomycin resistance in Escherichia coli isolated from pig. Vet Microbiol 162:964-967. http://dx.doi.org/10.1016/j.vetmic.2012.09.023.
14. Kim SY, Rhee JY, Shin SY, Ko KS. 2014. Characteristics of communityonset NDM-1-producing Klebsiella pneumoniae isolates. J Med Microbiol 63:86-89.
15. Damjanova I, Toth A, Paszti J, Hajbel-Vekony G, Jakab M, Berta J, Milch H, Fuzi M. 2008. Expansion and countrywide dissemination of ST11, ST15, and ST147 ciprofloxacin-resistant CTX-M-15-type β-lactamaseproducing Klebsiella pneumoniae epidemic clones in Hungary in 2005: the new MRSAs? J Antimicrob Chemother 62:978-985. http://dx.doi.org/10.1093/jac/dkn287.
16. Wang G, Huang T, Surendraiah PK, Wang K, Komal R, Zhuge J, Chern CR, Kryszuk AA, King C, Wormser GP. 2013. CTX-M β-lactamaseproducing Klebsiella pneumoniae in suburban New York city, New York, USA. Emerg Infect Dis 19:1803-1810. http://dx.doi.org/10.3201/eid1911.121470.
17. Richter SN, Frasson I, Franchin E, Bergo C, Lavezzo E, Barzon L, Cavallaro A, Palu G. 2012. KPC-mediated resistance in Klebsiella pneumoniae in two hospitals in Padua, Italy, June 2009 to December 2011: massive spreading of a KPC-3-encoding plasmid and involvement of nonintensive care units. Gut Pathog 4:7.
18. Giakkoupi P, Papagiannitsis CC, Miriagou V, Pappa O, Polemis M, Tryfinopoulou K, Tzouvelekis LS, Vatopoulos AC. 2011. An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009 to 2010). J Antimicrob Chemother 66:1510-1513. http://dx.doi.org/10.1093/jac/dkr166.
19. Lascols C, Peirano G, Hackel M, Laupland KB, Pitout JD. 2013. Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce carbapenemases: first report of OXA-48-like enzymes in North America. Antimicrob Agents Chemother 57:130-136. http://dx.doi.org/10.1128/AAC.01686-12.